Related references
Note: Only part of the references are listed.Discovery of 4-amino-1H-pyrazolo [3,4-d] pyrimidin derivatives as novel discoidin domain receptor 1 (DDR1) inhibitors
Ru Dong et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Discoidin domain receptors orchestrate cancer progression: A focus on cancer therapies
Yuan Gao et al.
CANCER SCIENCE (2021)
Design and Synthesis of DDR1 Inhibitors with a Desired Pharmacophore Using Deep Generative Models
Atsushi Yoshimori et al.
CHEMMEDCHEM (2021)
Small-molecule inhibitors of breast cancer-related targets: Potential therapeutic agents for breast cancer
Tingting Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present)
Xin Sun et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2021)
Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer
Yuping Zhao et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2021)
DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent
Gurubasavaraja Swamy Purawarga Matada et al.
MEDICINAL CHEMISTRY RESEARCH (2021)
Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer
Hossam Nada et al.
MOLECULES (2021)
Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
Kalpana K. Bhanumathy et al.
CANCERS (2021)
Complex roles of discoidin domain receptor tyrosine kinases in cancer
V. Mehta et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2021)
The role of DNA damage response in chemo- and radio-resistance of cancer cells: Can DDR inhibitors sole the problem?
Fatemeh Sadoughi et al.
DNA REPAIR (2021)
Inhibition of DNA damage response pathway using combination of DDR pathway inhibitors and radiation in treatment of acute lymphoblastic leukemia cells
Maryam Katoueezadeh et al.
FUTURE ONCOLOGY (2021)
The Yin and Yang of Discoidin Domain Receptors (DDRs): Implications in Tumor Growth and Metastasis Development
Sandra Majo et al.
CANCERS (2021)
The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model
Yuya Sannomiya et al.
RENAL FAILURE (2021)
Ligand-based pharmacophore mapping and virtual screening for identification of potential discoidin domain receptor 1 inhibitors
Ramar Vanajothi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Review on Epidermal Growth Factor Receptor (EGFR) Structure, Signaling Pathways, Interactions, and Recent Updates of EGFR Inhibitors
Dima A. Sabbah et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
A patent review of discoidin domain receptor 1 (DDR1) modulators (2014-present)
Jing Guo et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2020)
Discovery of VU6015929: A Selective Discoidin Domain Receptor 1/2 (DDR1/2) Inhibitor to Explore the Role of DDR1 in Antifibrotic Therapy
Daniel E. Jeffries et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Design and Optimization of 3′-(Imidazo[1,2-α]pyrazin-3-yl)-[1,1′-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors
Cheng Mo et al.
ACS MEDICINAL CHEMISTRY LETTERS (2020)
Collagen Kinase Receptors as Potential Therapeutic Targets in Metastatic Colon Cancer
Marie Lafitte et al.
FRONTIERS IN ONCOLOGY (2020)
Discoidin Domain Receptors, DDR1b and DDR2, Promote Tumour Growth within Collagen but DDR1b Suppresses Experimental Lung Metastasis in HT1080 Xenografts
Benjamin Wasinski et al.
SCIENTIFIC REPORTS (2020)
Small molecule tyrosine kinase inhibitors in glioblastoma
Gayoung Kim et al.
ARCHIVES OF PHARMACAL RESEARCH (2020)
Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease A Phase 2 Randomized Clinical Trial
Fernando. L. Pagan et al.
JAMA NEUROLOGY (2020)
Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer
Yu-Lian Chen et al.
CANCERS (2020)
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines
William H. Chappell et al.
AGING-US (2020)
Discoidin Domain Receptor 1 is a therapeutic target for neurodegenerative diseases
Alan J. Fowler et al.
HUMAN MOLECULAR GENETICS (2020)
Targeting Discoidin Domain Receptor 1 (DDR1) Signaling and Its Crosstalk with β1-Integrin Emerges as a Key Factor for Breast Cancer Chemosensitization upon Collagen Type 1 Binding
Fabian Baltes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma
Marie-Julie Nokin et al.
JCI INSIGHT (2020)
Rational modification, synthesis and biological evaluation of 3,4-dihydroquinoxalin-2(1H)-one derivatives as potent and selective c-Jun N-terminal kinase 3 (JNK3) inhibitors
Xiaodong Dou et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Discoidin Domain Receptors in Melanoma: Potential Therapeutic Targets to Overcome MAPK Inhibitor Resistance
Coralie Reger de Moura et al.
FRONTIERS IN ONCOLOGY (2020)
Autonomous molecule generation using reinforcement learning and docking to develop potential novel inhibitors
Woosung Jeon et al.
SCIENTIFIC REPORTS (2020)
Discovery and optimization of a series of 3-substituted indazole derivatives as multi-target kinase inhibitors for the treatment of lung squamous cell carcinoma
Qi Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Multikinase Abl/DDR/Src Inhibition Produces Optimal Effects for Tyrosine Kinase Inhibition in Neurodegeneration
Alan J. Fowler et al.
DRUGS IN R&D (2019)
Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy
Megan M. Tu et al.
SCIENCE ADVANCES (2019)
Dichotomy of the function of DDR1 in cells and disease progression
Yi-Chun Yeh et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Discoidin domain receptors: A promising target in melanoma
Coralie Reger de Moura et al.
PIGMENT CELL & MELANOMA RESEARCH (2019)
2-Amino-2,3-dihydro-1H-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer Efficacy
Dongsheng Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Alex Zhavoronkov et al.
NATURE BIOTECHNOLOGY (2019)
DDR1 promotes breast tumor growth by suppressing antitumor immunity
Xing Zhong et al.
ONCOLOGY REPORTS (2019)
New Concepts on the Interactions of Discoidin Domain Receptors with Collagen
Rafael Fridman et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2019)
Deep learning identifies DDR1 kinase inhibitors
Sarah Crunkhorn
NATURE REVIEWS DRUG DISCOVERY (2019)
DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome
Hans Richter et al.
ACS CHEMICAL BIOLOGY (2019)
Pharmacokinetics and pharmacodynamics of a single dose Nilotinib in individuals with Parkinson's disease
Fernando L. Pagan et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2019)
DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation
Yu-Shui Ma et al.
CANCER LETTERS (2018)
Tau clearance improves astrocytic function and brain glutamate-glutamine cycle
Michaeline L. Hebron et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2018)
Kinase-targeted cancer therapies: progress, challenges and future directions
Khushwant S. Bhullar et al.
MOLECULAR CANCER (2018)
Multitasking discoidin domain receptors are involved in several and specific hallmarks of cancer
Elodie Henriet et al.
CELL ADHESION & MIGRATION (2018)
A comprehensive review of protein kinase inhibitors for cancer therapy
Radhamani Kannaiyan et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2-a]pyrazin-3-ylethynyl)-4-isopropyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2
Zhen Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Signaling by discoidin domain receptor 1 in cancer metastasis
Mayur Gadiya et al.
CELL ADHESION & MIGRATION (2018)
Role of Extracellular Matrix in Development and Cancer Progression
Cameron Walker et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives
Veronica Vella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Receptor Tyrosine Kinase-Targeted Cancer Therapy
Toshimitsu Yamaoka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors
Lu Liu et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2017)
Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Wei Zhu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discoidin domain receptor inhibition reduces neuropathology and attenuates inflammation in neurodegeneration models
Michaeline Hebron et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors
Zhen Wang et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
The Role of Discoidin Domain Receptor 1 in Inflammation, Fibrosis and Renal Disease
Aude Dorison et al.
NEPHRON (2017)
Hit discovery of 4-amino-N-(4-(3-(trifluoromethyl)phenoxy)pyrimidin-5-yl)benzamide: A novel EGFR inhibitor from a designed small library
Ahmed Elkamhawy et al.
BIOORGANIC CHEMISTRY (2017)
Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma
Hoon Hur et al.
BMC CANCER (2017)
Discovery of a broad spectrum antiproliferative agent with selectivity for DDR1 kinase: cell line-based assay, kinase panel, molecular docking, and toxicity studies
Ahmed Elkamhawy et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2016)
Discovery of a Nanomolar Multikinase Inhibitor (KST016366): A New Benzothiazole Derivative with Remarkable Broad-Spectrum Antiproliferative Activity
Ashraf Kareem El-Damasy et al.
CHEMMEDCHEM (2016)
Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-RafV600E and C-Raf kinase inhibitory activities
Ashraf Kareem El-Damasy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors
Zhen Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Identification of novel inhibitors of DDR1 against idiopathic pulmonary fibrosis by integrative transcriptome meta-analysis, computational and experimental screening
Can Chen et al.
MOLECULAR BIOSYSTEMS (2016)
Modular Total Syntheses of the Alkaloids Discoipyrroles A and B, Potent Inhibitors of the DDR2 Signaling Pathway
Yiwen Zhang et al.
ORGANIC LETTERS (2016)
Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells
Qiu-Ping Lu et al.
ONCOLOGY LETTERS (2016)
Nilotinib Effects in Parkinson's Disease and Dementia with Lewy Bodies
Fernando Pagan et al.
JOURNAL OF PARKINSONS DISEASE (2016)
KRAS-driven lung adenocarcinoma: combined DDR1/Notch inhibition as an effective therapy
Chiara Ambrogio et al.
ESMO OPEN (2016)
Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer
Hideki Terai et al.
ACS CHEMICAL BIOLOGY (2015)
Targeting EGFR/HER2 tyrosine kinases with a new potent series of 6-substituted 4-anilinoquinazoline hybrids: Design, synthesis, kinase assay, cell-based assay, and molecular docking
Ahmed Elkamhawy et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery
Sandeepkumar Kethiwale et al.
DRUG DISCOVERY TODAY (2015)
Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives
Ashraf Kareem El-Damasy et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Small Molecule Discoidin Domain Receptor Kinase Inhibitors and Potential Medical Applications
Yupeng Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
NILOTINIB AND BOSUTINIB MODULATE PRE-PLAQUE ALTERATIONS OF BLOOD IMMUNE MARKERS AND NEURO-INFLAMMATION IN ALZHEIMER'S DISEASE MODELS
I. Lonskaya et al.
NEUROSCIENCE (2015)
DDR1 may play a key role in destruction of the blood-brain barrier after cerebral ischemia-reperfusion
Mingxia Zhu et al.
NEUROSCIENCE RESEARCH (2015)
Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
Christopher W. Murray et al.
ACS MEDICINAL CHEMISTRY LETTERS (2015)
Design and Synthesis of New [1,2,3]Triazolo[4,5-d]pyrimidine Derivatives as Potential Antiproliferative Agents
Ahmed Elkamhawy et al.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2015)
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor (vol 8, pg 2145, 2013)
Hyung-Gu Kim et al.
ACS CHEMICAL BIOLOGY (2014)
Discoidin domain receptor 2 facilitates prostate cancer bone metastasis via regulating parathyroid hormone-related protein
Zhang Yan et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
A novel mutation in DDR2 causing spondylometa-epiphyseal dysplasia with short limbs and abnormal calcifications (SMED-SL) results in defective intra-cellular trafficking
Adila Al-Kindi et al.
BMC MEDICAL GENETICS (2014)
Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma
Jinke Xu et al.
CANCER BIOLOGY & THERAPY (2014)
Discoidin domain receptors: a proteomic portrait
Leo K. Iwai et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Identification of Type II and III DDR2 Inhibitors
Andre Richters et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Structural Mechanisms Determining Inhibition of the Collagen Receptor DDR1 by Selective and Multi-Targeted Type II Kinase Inhibitors
Peter Canning et al.
JOURNAL OF MOLECULAR BIOLOGY (2014)
Nilotinib-induced autophagic changes increase endogenous parkin level and ubiquitination, leading to amyloid clearance
Irina Lonskaya et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial-mesenchymal transition programme under hypoxia
Tingting Ren et al.
JOURNAL OF PATHOLOGY (2014)
Discoidin domain receptors in disease
Corina M. Borza et al.
MATRIX BIOLOGY (2014)
Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor
Hyung-Gu Kim et al.
ACS CHEMICAL BIOLOGY (2013)
Nilotinib reverses loss of dopamine neurons and improves motor behavior via autophagic degradation of -synuclein in Parkinsons disease models
Michaeline L. Hebron et al.
HUMAN MOLECULAR GENETICS (2013)
Discoidin domain receptor 2 regulates the adhesion of fibroblasts to 3D collagen matrices
Daehwan Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2013)
Discoidin Domain Receptors: Unique Receptor Tyrosine Kinases in Collagen-mediated Signaling
Hsueh-Liang Fu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Discovery and Optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)-ethynyl)benzamides as Novel Selective and Orally Bioavailable Discoidin Domain Receptor 1 (DDR1) Inhibitors
Mingshan Gao et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Identification of GZD824 as an Orally Bioavailable Inhibitor That Targets Phosphorylated and Nonphosphorylated Breakpoint Cluster Region-Abelson (Bcr-Abl) Kinase and Overcomes Clinically Acquired Mutation-Induced Resistance against Imatinib
Xiaomei Ren et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Discoipyrroles A-D: Isolation, Structure Determination, and Synthesis of Potent Migration Inhibitors from Bacillus hunanensis
Youcai Hu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia
Vincenzo Pitini et al.
LUNG CANCER (2013)
The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis
Kun Zhang et al.
NATURE CELL BIOLOGY (2013)
Increased expression of discoidin domain receptor 2 (DDR2): a novel independent prognostic marker of worse outcome in breast cancer patients
Tingting Ren et al.
MEDICAL ONCOLOGY (2013)
Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung cancer and promotes cell invasion via epithelial-to-mesenchymal transition
Liyun Miao et al.
MEDICAL ONCOLOGY (2013)
A tale of two collagen receptors, integrin β1 and discoidin domain receptor 1, in epithelial cell differentiation
Yi-Chun Yeh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
DDR2 plays a role in fibroblast migration independent of adhesion ligand and collagen activated DDR2 tyrosine kinase
Mireya Liliana Herrera-Herrera et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Discoidin domain receptor tyrosine kinases: new players in cancer progression
Rajeshwari R. Valiathan et al.
CANCER AND METASTASIS REVIEWS (2012)
Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis
Karmele Valencia et al.
CLINICAL CANCER RESEARCH (2012)
Structure of the Discoidin Domain Receptor 1 Extracellular Region Bound to an Inhibitory Fab Fragment Reveals Features Important for Signaling
Federico Carafoli et al.
STRUCTURE (2012)
LCB 03-0110, a Novel Pan-Discoidin Domain Receptor/c-Src Family Tyrosine Kinase Inhibitor, Suppresses Scar Formation by Inhibiting Fibroblast and Macrophage Activation
Xiaoyan Sun et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Migration inhibition of mammary epithelial cells by Syk is blocked in the presence of DDR1 receptors
Brit Neuhaus et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Role of DDR1 in the gelatinases secretion induced by native type IV collagen in MDA-MB-231 breast cancer cells
Luis Castro-Sanchez et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Identification of Receptor Tyrosine Kinase, Discoidin Domain Receptor 1 (DDR1), as a Potential Biomarker for Serous Ovarian Cancer
Jinhua Quan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Discoidin Domain Receptor 1 Expression in Activated T Cells Is Regulated by the ERK MAP Kinase Signaling Pathway
Nizar Chetoui et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib
Melissa L. Johnson et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6
Cristina Hidalgo-Carcedo et al.
NATURE CELL BIOLOGY (2011)
Mutations in the DDR2 Kinase Gene identify a Novel therapeutic target in squamous cell lung cancer
Peter S. Hammerman et al.
CANCER DISCOVERY (2011)
Attenuation of Osteoarthritis Progression by Reduction of Discoidin Domain Receptor 2 in Mice
Lin Xu et al.
ARTHRITIS AND RHEUMATISM (2010)
Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patients
Bassam R. Ali et al.
HUMAN MOLECULAR GENETICS (2010)
Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non-Small-Cell Lung Cancer
Eric B. Haura et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II Study of Dasatinib in Patients With Advanced Non-Small-Cell Lung Cancer
Faye M. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion
Qingli Shen et al.
MOLECULAR CANCER (2010)
A comprehensive target selectivity survey of the BCR-ABL kinase inhibitor INNO-406 by kinase profiling and chemical proteomics in chronic myeloid leukemia cells
U. Rix et al.
LEUKEMIA (2010)
Discoidin Domain Receptor 2 (DDR2) Is Required for Maintenance of Spermatogenesis in Male Mice
Kiyoshi Kano et al.
MOLECULAR REPRODUCTION AND DEVELOPMENT (2010)
Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease
Oliver Gross et al.
MATRIX BIOLOGY (2010)
Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas
Sun Ho Yang et al.
ONCOLOGY REPORTS (2010)
Mutations in DDR2 Gene Cause SMED with Short Limbs and Abnormal Calcifications
Ruth Bargal et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
Marc M. Loriaux et al.
BLOOD (2008)
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
Michael H. Tomasson et al.
BLOOD (2008)
Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib
Elizabeth Day et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
A novel dwarfism with gonadal dysfunction due to loss-of-function allele of the collagen receptor gene, Ddr2, in the mouse
Kiyoshi Kano et al.
MOLECULAR ENDOCRINOLOGY (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1
Angela M. Meyer zum Gottesberge et al.
LABORATORY INVESTIGATION (2008)
Prostate cancer antigen-1 contributes to cell survival and invasion though discoidin receptor 1 in human prostate cancer
Keiji Shimada et al.
CANCER SCIENCE (2008)
Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer
Klarisa Rikova et al.
CELL (2007)
Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib, reveal novel kinase and nonkinase targets
Uwe Rix et al.
BLOOD (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
Expression and mutation analysis of the discoidin domain receptors 1 and 2 in non-small cell lung carcinoma
C. E. Ford et al.
BRITISH JOURNAL OF CANCER (2007)
Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease
Martin Flamant et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors
Anne Couvelard et al.
GASTROENTEROLOGY (2006)
Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis
Carmel Avivi-Green et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Sensing extracellular matrix: An update on discoidin domain receptor function
Wolfgang F. Vogel et al.
CELLULAR SIGNALLING (2006)
A general strategy for creating Inactive-conformation Abl inhibitors
Barun Okram et al.
CHEMISTRY & BIOLOGY (2006)
DDR1 signaling is essential to sustain Stat5 function during lactogenesis
E Faraci-Orf et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Somatic mutations of the protein kinase gene family in human lung cancer
H Davies et al.
CANCER RESEARCH (2005)
Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymohoma
C Renné et al.
BLOOD (2005)
Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling - Potential implications in atherosclerosis and lymphangioleiomyomatosis
N Ferri et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Activation of discoidin domain receptor 1 isoform b with collagen up-regulates chemokine production in human macrophages:: Role of p38 mitogen-activated protein kinase and NF-κB
W Matsuyama et al.
JOURNAL OF IMMUNOLOGY (2004)
Overexpression of the cell adhesion molecules DDR1, claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer
VA Heinzelmann-Schwarz et al.
CLINICAL CANCER RESEARCH (2004)
Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis
JA Squire et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2002)
Discoidin domain receptor 1 isoform-a (DDR1a) promotes migration of leukocytes in three-dimensional collagen lattices
H Kamohara et al.
FASEB JOURNAL (2001)
The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism
JP Labrador et al.
EMBO REPORTS (2001)
Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development
WF Vogel et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Consistent and selective expression of the discoidin domain receptor-1 tyrosine kinase in human brain tumors
HL Weiner et al.
NEUROSURGERY (2000)
Share Paper
